NovaVision, the US company producing a controversial visual rehabilitation programme, has been bought by Vycor Medical, producers of neurosurgical retraction devices. The NovaVision method has been around for some years since their original trial was published in Nature Medicine. Unfortunately this trial was very significantly flawed, and the method has been the subject of controversy ever since.
News article on completion of Vycor acquisition (12 January 2011)
News article on commencement of Vycor acquisition (11 November 2010)
The Oregon Hemianopsia Support Group met at the Casey Eye Instiute of Oregon Health and Sciences University, Monday,January 24th. Dr. Krystel Huxlin spoke to the group from Rochester and reviewed her own training program research. She also noted NovaVision was flawed in the way the patient group was evaluated. Her research is very careful in how the patient visualizes the training. Randall, Portland, Oregon USA
ReplyDeleteI hold Dr Huxlin's work in very high regard.
ReplyDelete